11-13 November 2025
Congress Center Basel - Basel, Switzerland
Welcome to TIDES Europe 2025
Join Europe’s premier oligonucleotides conference where world-renowned speakers and leading companies share breakthrough insights across oligonucleotides, peptides, mRNA, drug delivery, and partnering strategies—from discovery to market.
Experience cutting-edge data, inspiring keynotes, interactive workshops, and meaningful connections with the innovators shaping therapeutic development. This is where tomorrow’s healthcare breakthroughs are born and industry-defining partnerships begin.
The future of therapeutics is being written. Make sure you’re part of the story.
Connect with the Top Companies Leading The Way in Oligonucleotide & Peptide Therapeutics
Start Connecting
Pre-Conference Workshops
11 November 2025
9:00AM - 12:00PM
Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Sonja Merkas, PhD, Livinovea
Chris Oswald, Coswald Consulting LLC
Thomas Rupp, Axolabs
9:00AM - 12:00PM
Innovations and Challenges in Peptide Manufacturing
Robert Hagopian, PolyPeptide Group
Alaric Desmarchelier, PhD, Almac Group
Marc Jacob, PhD, YMC America
Dr. Toshiki Mikami, PhD, Novartis
9:00AM - 12:00PM
Digital Innovation and Technology in Oligonucleotide Development
Nadim Akhtar, PhD, AstraZeneca
Barrie Cassey, PhD, CPI
Ross Kelly, PhD, AstraZeneca
Martin Olbrich, PhD, F Hoffmann-La Roche Ltd.
Guido Creusen, PhD, F. Hoffmann-La Roche Ltd.
Philipp Weber, F. Hoffmann-La Roche AG
Lucrece Nicoud, PhD, Ypso-Facto
Leaders in Oligonucleotide & Peptide Therapeutics
You can view all these speakers and more using our filter options in the Agenda here:
Networking Events
Daily Networking Breaks
Evening Receptions
Early Morning Fun Run, 12 November 6:30 am-7:30 am
Tracks and Descriptions
Oligonucleotide Discovery, Preclinical and Clinical
Oligonucleotide Chemistry, Manufacturing and Controls
Peptide Discovery to CMC
Explore new frontiers in peptide synthesis, discovery, design, and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.